Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.3900
-0.0300
(-2.11%)
At close: February 28 at 3:29:01 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in AUD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 7.48M | 17.57M | 358.36M | 2.6B |
| Low Estimate | 7.48M | 17.57M | 358.36M | 2.6B |
| High Estimate | 7.48M | 17.57M | 358.36M | 2.6B |
| Year Ago Sales | -- | -- | 8.7M | 358.36M |
| Sales Growth (year/est) | -- | -- | 4,018.99% | 626.15% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LWB.F | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.62% | 14.20% |
Related Tickers
1VT.F Viking Therapeutics, Inc.
27.90
+2.35%
NGENF NervGen Pharma Corp.
1.9150
-0.26%
CNTB Connect Biopharma Holdings Limited
0.9099
+1.10%
PHRRF PharmaTher Holdings Ltd.
0.1420
+4.80%
KYTX Kyverna Therapeutics, Inc.
2.8400
+1.43%
LYRA Lyra Therapeutics, Inc.
0.2140
+5.52%
ATHE Alterity Therapeutics Limited
3.7800
-2.33%
ABEO Abeona Therapeutics Inc.
5.24
+1.95%
TSHA Taysha Gene Therapies, Inc.
1.6000
+0.63%
MURA Mural Oncology plc
3.6800
+0.55%